AI Article Synopsis
- The study focuses on peri-pancreatic sporadic gastrinoma, a condition linked to abnormal gastrin secretion that leads to Zollinger-Ellison syndrome.
- A 42-year-old patient with a bleeding duodenal ulcer was diagnosed with a primitive peri-pancreatic gastrinoma and subsequently underwent surgery to remove the tumor.
- The study concludes that sporadic gastrinoma is rare and highlights the importance of advanced imaging techniques for diagnosis, emphasizing that surgery is the only curative treatment available.
Article Abstract
Background: The peri-pancreatic sporadic gastrinoma represents a paradigm of digestive endocrinology. It was originally an abnormal secretion of gastrin fits the syndrome Zollinger-Ellison.
Aim: The objective of our work is to clarify the diagnostic strategy and therapeutic conduct of gastrinoma.
Case: We report the case of a patient aged 42 years, hospitalized for bleeding duodenal ulcer, revealed a Zollinger-Ellison syndrome. The different explorations have shown that it was a primitive péripancréatique sporadic gastrinoma. In surgery, we discover a rétropancréatique tumor associated to a stenosis post-bulbar ulcer. It was conducted a enucleation of the tumor with vagotomie troncular and gastroenteroanastomosis. The forecast was favourable with normalization of the values of gastrinémie.
Conclusion: The sporadic gastrinoma is rare, its emphasis is increasingly being facilitated by the technology of modern medical imaging, belonging to a polyendocrinopathie must be systematic search. Treatment of pancreatic gastrinoma is multidisciplinary. Surgery is the only cure for this disease.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!